Aprea Therapeutics, Inc.

APRE • NASDAQ • Stock Fundamentals

Aprea Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Oren Gilad, with a market cap of $11.3M.

Market Cap$11.3M

Employees7.0

CEOOren Gilad

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. (APRE) has a market capitalization of $11.3M and trades on NASDAQ.

Aprea Therapeutics, Inc. has approximately 7 employees.